Triple Negative Breast Neoplasms  >>  iniparib (BSI 201)  >>  Phase N/A
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
iniparib (BSI 201) / Sanofi
NCT01130259: An Open-Label, Expanded Access Protocol of Iniparib Breast Cancer

No Longer Available
N/A
US
iniparib, BSI-201
Sanofi
Breast Cancer
 
 

Download Options